-
A Treatment That Came Just in Time
Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.
by Laurie Adami
-
Immunotherapy Indications Withdrawn
In recent months, drugmakers have announced they are withdrawing indications for four immune checkpoint inhibitors in consultation with the Food and Drug Administration. What does this mean for patients who are taking these drugs?
by Anna Goshua
-
Testing COVID-19 Treatments for Patients With Cancer: An Ongoing Need
Researchers are studying the effectiveness of drugs for treating COVID-19 in cancer patients who have been infected with the coronavirus.
by Marcus A. Banks
-
Immunotherapy Options for Breast Cancer
Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.
by Anna Goshua
-
Liquid Biopsies May Ease Enrollment in Clinical Trials
A study shows that a blood test for gastrointestinal tumor mutations gave results in a third of the time needed for solid tissue testing. Patients who received the blood test were more likely to enroll in clinical trials.
by Emma Yasinski
-
What Is Tumor Mutational Burden?
The Food and Drug Administration approved an immunotherapy drug for tumors with high tumor mutational burden regardless of tumor type. But some medical oncologists say it's not clear the biomarker is valid across all cancer types.
by Anna Azvolinsky
-
Targeted Therapy for Early-Stage Lung Cancer?
A trial of the targeted therapy Tagrisso (osimertinib) for early-stage lung cancer finds that patients who take it go longer without having a cancer recurrence. Whether that should change clinical practice is under discussion.
by Ashley P. Taylor
-
Trials Interrupted
COVID-19 slowed or stopped enrollment in some cancer clinical trials.
by Kate Yandell
-
Facing Cancer and a Pandemic at the Same Time
Cancer patients and their families share stories of fear, love and uncertainty as they find new ways to support each other.
by Jen Tota McGivney
-
The Coronavirus Impacts Cancer Clinical Trials
The National Cancer Institute and the Food and Drug Administration have provided guidance for managing clinical trials amid the spread of the novel coronavirus. Cancer centers are making changes to care for some patients enrolled in trials.
by Anna Azvolinsky
Cancer Talk
New studies find that electronic cigarettes trail other methods in helping people quit smoking, but they are growing in popularity among teens.
by Teresa Bergen
A Look at Disparities Across Cancer CareA new AACR report tracks progress in addressing cancer health disparities and identifies work that still needs to be done.
by Eric Fitzsimmons
Credit Agencies to Remove Some Medical Debt From ReportsChanges to what medical debt is included in credit reports could give patients more time to resolve outstanding bills.
by Karon Warren
The Mental Toll of a Cancer DiagnosisNew studies shine a light on the effects of a cancer diagnosis on mental health and suicide risk.
by Pamela Rafalow Grossman
From the AACR
-
Using Lymphocytes to Attack Tumors
Sooner rather than later may be the best strategy for using an experimental treatment for advanced melanoma.
-
Closing Disparities Through Genetic Testing
Olufunmilayo Olopade seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
-
AACR and AACI Collaborate to Advocate for Cancer Research Funding
Federal funding could help cancer centers rebuild from the devastating effects of the pandemic.
Video
Learning Medicare’s ABCDs
